MELISSA CANNON: Open Payments
NPI 1801292412 · WATKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 24 payments from 12 companies in 2025. Trend: 2023 $754 · 2024 $1,049 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| ABBVIE INC. | 4 | $74 |
| GENZYME CORPORATION | 2 | $72 |
| Galderma Laboratories, L.P. | 4 | $67 |
| PFIZER INC. | 3 | $53 |
| Incyte Corporation | 1 | $25 |
| Organon LLC | 1 | $23 |
| Amgen Inc. | 1 | $23 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $21 |
| Surgenex LLC | 1 | $18 |
Products named: DUPIXENT, NEMLUVIO, CIBINQO, SKYRIZI, Rhapsido, COSENTYX, OPZELURA, VTAMA.
Industry payments across GA — which companies pay providers there.
